Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

May 15, 2024

Study Completion Date

December 31, 2024

Conditions
Hereditary Dysfibrinogenemia
Interventions
BIOLOGICAL

Blood test

"For each patient included, this study will involve the collection of 20 ml of blood during a blood test carried out as part of routine care. One EDTA tube (4,5 ml) will be withdrawn and frozen for genetic testing. 15 ml of citrated blood sample (3 to 5 tubes, depending on the used tubes) are necessary for the study of fibrin clot structure. Citrated tubes will be double centrifugated and frozen (-80°C) according to Groupe Français d'Études sur l'Hémostase et la thrombose guidelines (centrifugation protocol: 1500 to 2000g at least 15min, or 2000 to 2500g at least 10min with an intermediate decantation)."

Trial Locations (7)

Unknown

CHU clermont-ferrand, Clermont-Ferrand

CHU Dijon, Dijon

CHU de Lille, Lille

CHU Montpellier, Montpellier

CHu Nancy, Nancy

CHU Nantes, Nantes

CHU Tours, Tours

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER